M. Elwenspoek, Athena Sheppard, M. McInnes, S. Merriel, E. Rowe, R. Bryant, J. Donovan, P. Whiting (2019)
Comparison of Multiparametric Magnetic Resonance Imaging and Targeted Biopsy With Systematic Biopsy Alone for the Diagnosis of Prostate CancerJAMA Network Open, 2
F. Schröder, J. Hugosson, M. Roobol, T. Tammela, M. Zappa, V. Nelen, M. Kwiatkowski, M. Luján, L. Määttänen, H. Lilja, L. Denis, F. Recker, Á. Páez, C. Bangma, S. Carlsson, D. Puliti, A. Villers, X. Rébillard, M. Hakama, U. Stenman, P. Kujala, K. Taari, G. Aus, A. Huber, T. Kwast, R. Schaik, H. Koning, S. Moss, Anssi Auvinen (2014)
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-upThe Lancet, 384
A. Bill-Axelson, L. Holmberg, H. Garmo, K. Taari, C. Busch, S. Nordling, M. Häggman, S. Andersson, O. Andrén, G. Steineck, H. Adami, J. Johansson (2018)
Radical Prostatectomy or Watchful Waiting in Prostate Cancer — 29‐Year Follow‐upThe New England Journal of Medicine, 379
T. Stamey, N. Yang, A. Hay, J. McNeal, F. Freiha, E. Redwine (1987)
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateThe New England Journal of Medicine, 317
H. Grönberg, M. Eklund, W. Picker, M. Aly, F. Jäderling, J. Adolfsson, M. Landquist, E. Haug, P. Ström, S. Carlsson, T. Nordström (2018)
Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging.European urology, 74 6
W. Catalona, Deborah Smith, T. Ratliff, K. Dodds, D. Coplen, J. Yuan, J. Petros, G. Andriole (1991)
Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.The New England journal of medicine, 324 17
R. Siegel, K. Miller, A. Jemal (2016)
Cancer statistics, 2016CA: A Cancer Journal for Clinicians, 66
F. Hamdy, J. Donovan, J. Lane, M. Mason, C. Metcalfe, P. Holding, M. Davis, Tim Peters, E. Turner, Richard Martin, J. Oxley, M. Robinson, J. Staffurth, E. Walsh, P. Bollina, J. Catto, A. Doble, A. Doherty, D. Gillatt, R. Kockelbergh, H. Kynaston, A. Paul, P. Powell, S. Prescott, D. Rosario, E. Rowe, D. Neal, D. Neal (2017)
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.The New England journal of medicine, 375 15
H. Welch, W. Black (2010)
Overdiagnosis in cancer.Journal of the National Cancer Institute, 102 9
N. Dubrawsky (1989)
Cancer statisticsCA: A Cancer Journal for Clinicians, 39
V. Kasivisvanathan, A. Rannikko, M. Borghi, V. Panebianco, L. Mynderse, M. Vaarala, A. Briganti, L. Budäus, G. Hellawell, R. Hindley, M. Roobol, S. Eggener, M. Ghei, A. Villers, F. Bladou, G. Villeirs, J. Virdi, S. Boxler, G. Robert, Paras Singh, W. Venderink, B. Hadaschik, A. Ruffion, Jim Hu, D. Margolis, S. Crouzet, L. Klotz, S. Taneja, P. Pinto, I. Gill, C. Allen, F. Giganti, A. Freeman, S. Morris, S. Punwani, N. Williams, C. Brew-Graves, J. Deeks, Y. Takwoingi, M. Emberton, C. Moore (2018)
MRI‐Targeted or Standard Biopsy for Prostate‐Cancer DiagnosisThe New England Journal of Medicine, 378
JAMA network open – Pubmed
Published: Jun 4, 2020
Access the full text.
Sign up today, get DeepDyve free for 14 days.